Report - Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy · 2020. 5. 16. · placebo-controlled study in CMV seropositive allogeneic HCT recipients [22••]. A subset of patients

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form